50 Followers SGX:T14 - Tianjin ZX USD (USD 0.78) TIANJIN ZHONG XIN PHARM GROUP
Sector: Health Technology, Industry: Pharmaceuticals: Other
Add to Watchlist
Add Alert 

Yahoo Finance

USD 0.78    -0.025 (-3.11%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Sep 2020


21 Sep 2020

52 Wk Range: 0.505 - 0.99

Day's Range: 0.78 - 0.8

Last Volume: 230,000

Current Yield: 5.43%

Projected Yield: 5.68%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

21 Sep 2020

Metric T14 S.Median
Beta 0.84 0.14
VaR 20.92 50.49
E.Shortfall 26.88 94.2
Liquidity 255.21K 969.25K


21 Sep 2020

PE: 7

Market Cap: 600.5M

Price Over Book: 0.774

Price Over Sales: 0.63

Return On Assets: 7.6%

Return On Equity: 11.3%

Shares By Insiders: 76%


CEO: Yan Li

Founded Year: 1992

Headquarters: Tianjin

Employees: 4,720

Shares Outstanding: 768.9M

Sector: Health Technology

Industry: Pharmaceuticals: Other

Useful Links


Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.